AT NISHITH DESAI ASSOCIATES
Dr. Milind Antani, a renowned surgeon turned lawyer, leads the Pharma & Healthcare practice at multi-skilled, research-based international law firm, Nishith Desai Associates where he represents high net-worth clients in matters allied to JVs, M&As, VC and Private Equity investments, Collaborations, Regulatory advice, IP, Licensing and Commercialization. He also leads the Social Sector Practice and represents various global and national foundations in India.

AREAS OF PROVEN EXPERTISE
He has authored and co-authored numerous articles and prestigious publications related to the Pharma and Healthcare industry. Various national as well as international publications such as Digital Health Legal, a Cecil Media Publication in UK continue to reach out to Dr. Antani for insights and have carried his word. A regular speaker at various prominent forums on Pharma, Medical Devices, Med-Tech & eHealth, Biotech, IP, Clinical trials, Healthcare, CSR and Social Impact investments, he is also a visiting faculty at premier institutions in Mumbai and Gujarat including the Institute of Rural Management, Anand (IRMA).

PUBLISHED AUTHOR
Dr. Antani has co-authored the magnum opus “Contract Research and Manufacturing Services (CRAMS) in India: The Business, Legal, Regulatory and Tax Environment in the Pharmaceutical and Biotechnology Sectors, a Woodhead Publishing Series in Biomedicine and Indian Pharma and Life Science Industry- Legal and Tax Framework published by CCH, A Walter Kluwer business.

OUT OF OFFICE
Dr. Antani is a firm believer in the adage, “Soft Skills are the Hard Skills,” by Amy Edmondson, professor of leadership and management at Harvard Business School (‘Doc’ has also successfully completed a certificate course in professional services marketing from Harvard) and to this extent is a certified Soft Skills trainer. A voracious reader, given his love for assimilating knowledge across fields and varied thought pools, he pegs ‘Jonathan Livingstone Seagull’ by Richard Bach, ‘See you at the Top’ by Zig Ziglar and ‘Na-Hanyate’ by Maitreyi Devi as his favorites. He also enjoys watching the good ole telly and is a fan of Gujrati plays.

MedTech Europe (2012 - ) – Medical Technologies
Currently and for the last 6 years – CEO MedTech Europe.
Medtech Europe is the European association which represents the interest of the MedTech Industry in Brussels (Staff of 45 people - dealing with Brussels – EU institutions and Health stakeholders) and in Europe through the network of over 45 National trade Associations all members of MedTech Europe. MedTech Europe is composed of Medical device companies, IVD companies, National Associations and others which individual associations merged in December 2016.

Medtronic (2007 – 2012) – Medical Devices
President Medtronic France and Vice President Medtronic Europe – (5 years) (Paris, France)
President of APIDIM (trade association of US MedTech Companies in France) and Vice-president / treasurer of SITEM (French trade Association of MedTech).

Schering Plough (1998 – 2007) - Pharma
Vice President, Middle East Africa – Schering Plough (Pharma) (5 Years) - (Dubai, UAE)
8 affiliates reported into the function.
Director, BU Respiratory, Schering -Plough France – 4 years (Exec. Committee)

Johnson & Johnson – 17 years (1981 – 1998) - Pharma
Janssen-Cilag – Paris (France) (4 years)
Lead integration of Cilag & Janssen in France, BU Director, Sales Administration & Training Director. (Exec. Committee)
Cilag International – Zurich (Switzerland) (3 years):
International Business Development Director (Derm/Gynecology Franchises)
Ortho Pharmaceuticals – Derm Division – US (11 years):
Sales Rep, Mkt Research, product manager, Regional Sales manager, Marketing Director.

Background
Paris Business School – MBA (Paris)
American Graduate School of International Management (Thunderbird) – MIM – (Phoenix, Arizona)
Marrried - 4 kids!

Ian is CEO of the Medical Technology Association of Australia, the national association representing companies in the medical device industry.

Ian is a director of the Asia Pacific Medical Technology Association, which is headquartered in Singapore, and is also a director and Vice Chair of Red Nose, formerly known as SIDS & Kids, a well-respected not-for-profit organisation that is dedicated to saving the lives of babies and children.

Ian has a varied career in both not-for-profit and commercial organisations and his previous CEO roles have included the Australian Dental Association (NSW), the Australian Orthopaedic Association and a private equity backed health business with more than 350 staff.

Ian is a member of the Australian Institute of Company Directors and holds an MBA from Macquarie University and a Bachelor of Economics from the Australian National University.

Campbell Clark is Vice President, Legal and Compliance, Asia Pacific, for Medtronic, a healthcare company, and is based in Singapore. He was previously the Chief Ethics & Compliance Officer, Asia Pacific, for Medtronic. Prior to joining Medtronic, Campbell was General Counsel, Asia, for Covidien, another healthcare company which was acquired by Medtronic in January 2015. He has also held senior roles in-house as an international legal counsel in Australia and Japan, and in private practice as a litigation lawyer in New Zealand and the United Kingdom. Campbell graduated from the University of Auckland, New Zealand, and holds an LL.B (Hons) and M.Jur (Dist.).

Since 2015, Campbell has been the Chair of the Legal/Ethics & Compliance Committee of the Asia Pacific Medical Technology Association (APACMed).

Rupert is a Principal based in Singapore, leading complex consulting engagements, advisory support and training across Asia-Pacific. Rupert has spent the past 17 years in risk management, gaining frontline experience in over 35 countries, across 30 industries, including healthcare, service, technology, manufacturing, government and non-governmental organisations. Examples of Rupert’s recent experience include:

 Conducted investigations and responded to crises involving possible or actual regulatory, security or criminal breaches. This included terrorist incidents, whistleblower allegations, fraud, corruption, cyber or physical threats and human rights violations.
 Advised clients in multiple sectors concerned about how best to manage their businesses in compliance with ethical and regulatory provisions in markets across Asia. This included corruption, ethics and/or fraud risk assessments; gap analysis and benchmarking; implementation support; and scenario-based ethics, crisis and compliance workshops.
 Worked with over 400 frontline staff facing extortive pressure, threats and/or unethical demands from public officials or their commercial/criminal associates, developing practicable crisis response and risk mitigation tactics.

Rupert is a regular commentator and speaker on crisis, political and compliance issues focused on Asia. Rupert was previously the director of country risk analysis for Asia-Pacific, associate director in the South-east Asia investigations team, and prior to that, practice leader for the Western Europe investigations team, based in London. Before joining Control Risks, Rupert worked in crisis response, specialising in handling terrorism, extortion and political risk issues.

Rupert holds a bachelor’s honours degree in Business Administration from the University of Bath, a Postgraduate Certificate in Behavioural Analysis and Investigative Interviewing, and is pursuing postgraduate studies focusing on deception detection.

Gareth is Vice President of Legal & Compliance, Asia Pacific for Cardinal Health. He also serves on Cardinal Health’s Asia Pacific Leadership Team where he provides a broad and risk-weighted perspective on business strategies and operations. Gareth is also a member of Cardinal Health’s Global Legal and Compliance Committee which is tasked with driving the company’s legal and compliance strategy as the company expands its global footprint.

With 24 years of experience as a legal professional, Gareth started his legal career in 1995 as a solicitor in the commercial & banking practice with a leading Singapore law firm and thereafter as legal counsel with increasing scope & responsibilities in oil & gas companies like Royal Dutch Shell & Halliburton.

Gareth first came into the healthcare industry in 2006 where he was appointed Baxter Healthcare’s Senior Counsel, India & South East Asia. Between August 2009 and May 2015, he served as Allergan’s General Counsel & Chief Compliance Officer, Asia Pacific. He joined Cardinal Health in August 2015.

Gareth holds a bachelor’s degree in economics and a bachelor’s degree in law with honors from Monash University, Australia. He has been admitted as an Advocate & Solicitor, Supreme Court of Singapore, and enrolled as a Solicitor, Supreme Court of England & Wales.

Kengo Nishigaki joined Baker McKenzie in 2000. From 2004 to 2005, he worked at the Firm’s Chicago office, where he assisted a major manufacturer of defense-related products with matters involving compliance with the US Foreign Corrupt Practices Act (FCPA). Kengo regularly lectures on issues related to fraud and anti-bribery investigations. He is admitted to practice in Japan and New York.
Kengo’s practice focuses on advising Japanese and foreign listed companies on fraud investigations and compliance with anti-corruption laws, including the US Foreign Corrupt Practices Act, the UK Bribery Act and the Unfair Competition Prevention Act of Japan. He also co-chairs the Healthcare Industry Group of Baker & McKenzie Tokyo, and advises not only on anti-bribery issues but also industry-specific regulatory affairs. He also assists major Japanese and foreign-listed companies in litigation and other types of dispute resolution, such as arbitration and mediation.

Fredrik brings 30 years experience in the medical technology industry, 24 of which were spent in Asia-Pacific. He has worked across the region and lived in Singapore, Malaysia and Japan.

He has a background in both senior strategic consulting roles and in operational sales, marketing and general management positions.

Fredrik has also worked extensively with start-up medical technology companies both as advisor and as venture capitalist. He was most recently Senior Director and medical technology Practice Lead at Quintiles Consulting, based in Singapore.

He began his career in Asia with Ohmeda, now separate units of GE Healthcare, Becton Dickinson and Baxter.

Fredrik holds a BSc from Gothenburg University, Sweden, and an MBA from Henley Management College, UK.

Ash Raivadera is Head of the Partner Practice Group for South Asia, establishing our Singapore office in 2016. He works closely with his colleagues throughout the region and world to present and identify more opportunities with major international laws firms. With a focus on senior-level search, Ash works closely with his Associate Practice Group colleagues in Hong Kong to help firms in Singapore fill their more junior needs as well.

As a father of three girls, Ash, along with his wife, spends most of his spare time ferrying the kids to ballet, netball, music and drama classes. Ash is also a keen cricketer, still playing the veterans version of the game, which is much slower than it used to be.

EXPERIENCE
Ash is an English-qualified solicitor who spent five years in London law firms before heading to Singapore. He moved to Singapore in 1999, where he embarked on a career in legal recruitment with an Asian-based executive search firm. In January 2001, he joined the Singapore office of global recruitment specialist Robert Walters, where he helped establish and run the legal recruitment desk for Southeast Asia. From there, he moved to global legal recruitment specialist Hughes-Castell as a senior consultant and business development manager in 2003, leaving them at the end of 2005 to establish his own firm, ATR Associates Pte Ltd.

He has extensive experience assisting international law firms, banks and international corporations in various industry sectors. In more recent years, Ash worked on counsel and partner placements with international law firms in Singapore and Southeast Asia, providing strategic advice and detailed market analysis to global, regional and local heads.

PLACEMENTS
As the region has grown, Ash has become involved in helping firms to find a solution for their Singapore law offering or a Jakarta office solution. Recent work in this area includes assisting a major global firm to restructure their offering in Jakarta and helping a UK city firm to find a Singapore law firm to engage in an alliance.

Ash has also helped US firms and English City practices open their offices in Singapore – recently working with a growing UK firm to open a Singapore office and helping a large US firm to open an office in Singapore.

Other examples of work done in the region:
• Lead arbitration partner into a global practice in Singapore (partner was identified to also lead the Singapore local law firm offering of the international practice)
• Lead energy partner into a market leading US energy practice to expand the South Asian offering
• Lead power/projects partner into a market leading US firm where the partner is now managing partner

EDUCATION
De Montfort University, Leicester, UK: Common Professional Exam and Law Society Finals
University of York, UK: BA, Economics, with honors
Loughborough Grammar School: A Levels/Head of School

ASSOCIATIONS
Solicitor (England & Wales)

Clara is Managing Director, Emerging Asia, for all 3 BUs in Cardinal Health – Medical Solutions: Specialty and General Medical; and Cordis . Emerging Asia is the most diverse region in Asia Pacific covering 18 countries. Clara holds full responsibilities for the business including defining the commercial strategy, Go-to-market model and driving significant revenue and profit growth. Clara is a member of the Asia Pacific Leadership Team in Cardinal Health.

Clara has more than 25 years of experience both in sales and marketing roles in the Asia healthcare arena. She started her career as a sales representative and progressed to take on customer service and communication roles. She started her career in healthcare when she joined Siemens Medical Instruments as Marketing Manager for Asia Pacific. Subsequently, she moved on to join Abbott Diabetes Care in 2003 as Marketing Manager for South Asia. She took on more responsibilities and was promoted to Regional Director for Southeast Asia, Pakistan.

Clara was also Regional Director for Southeast Asia and Country Manager of Philippines in Becton Dickinson. Before joining Cardinal Health, Clara was Marketing Director, Asia Pacific and Emerging Market in Smith & Nephew, Advanced Wound Care.

Clara holds a Bachelor of Science degree with National University Of Singapore with majors in Chemistry and Mathematics. She obtained her Master Degree in Business in 2000 with University Of Adelaide.

Legal and compliance professional. UK solicitor. Admitted 1985. Since 2017 proprietor of own consultancy services.

5 years private practice in London. 27 years as in-house counsel. 2 years BTR plc (Invensys plc), 23 with GlaxoSmithKline, 2 years Kimberly Clark. Since 2000 based in Singapore as regional General Counsel APAC.

Currently an Associate member respectively of APACMed, Singapore Academy of Law, SIArb, Singapore Corporate Counsel Association and co-convenor of its Well-Being Chapter.

Experienced in transactions, stakeholder/matrix management & investigations. FCPA /U.K. Bribery Act advisory work, crisis manager. Coach/mentor.

Participation on various governance committees and commercial executive leadership teams.

YUET MING THAM is a global head of Sidley’s Government Enforcement & Investigations Group and Chair of the firm’s Asia Pacific Diversity & Inclusion Committee.
Yuet has a special focus on the Life Sciences industry and represents more than 30 different life sciences clients from the U.S. and Europe. Yuet advises international corporations on anti-bribery laws (including the FCPA), employment law and data privacy. In the area of Life Sciences, she has extensive experience advising a large number of major U.S. and European medical devices companies on compliance, clinical trials, labeling, promotional and marketing regulations, patient assistance programs as well as a variety of contractual matters, such as distribution agreements and the termination of distributors.
She speaks fluent English, Mandarin, Cantonese and Malay, and is licensed to practice law in New York, England & Wales, Hong Kong and Singapore.
Yuet has been awarded the Emerging Markets “Compliance & Investigations Lawyer of the Year” by The Asian/American Lawyer, with the team additionally recognized as the “Compliance/Investigations Firm of the Year”. She has been acknowledged as a “Leading Lawyer” by Chambers Asia Pacific and Chambers Global across four categories namely “Dispute Resolution: Litigation,” “Corporate Investigations/Anti-Corruption,” “Life Sciences” and “Financial Services: Contentious Regulatory.” Additionally, Yuet is recognized in the “Financial Services Regulatory” category by IFLR1000 as a “Leading Lawyer” and has also been listed by Who’s Who Legal as a “Leading Business Lawyer” in three separate categories namely “Life Sciences,” “Business Crime Defense” and “Investigations.” The 2016 edition regarded her as “one of the best-informed regulatory lawyers in the region” for the life sciences sector. Under the Corporate Investigations & Anti-Corruption chapter of the 2018 edition of Chambers Asia Pacific, Yuet is described by clients as being “exceptionally bright” and “very responsive and knowledgeable and can immediately dive into the issues.” In the Life Sciences chapter, clients lauded their experience working with Yuet: “We have always been impressed by her leadership, professionalism, tenacity and savvy technical skills. You will love to work with Yuet.”
Prior to joining Sidley, Yuet was a Deputy Public Prosecutor in Singapore and previously the Asia Pacific Regional Compliance Director for Pfizer. During that time, she carried out investigations in Japan, China, Australia, Korea, India, Indonesia, Thailand, Taiwan, Hong Kong, Malaysia, Singapore and the Philippines.
Yuet is frequently invited to speak at major conferences around the world on the FCPA and data privacy.